Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Kenneth B. Ain"'
Publikováno v:
Médecine Nucléaire
Médecine Nucléaire, Elsevier/Masson, 2020, 44, pp.287-289. ⟨10.1016/j.mednuc.2020.06.002⟩
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique, 2020, 44, pp.287-289. ⟨10.1016/j.mednuc.2020.06.002⟩
Médecine Nucléaire, Elsevier/Masson, 2020, 44, pp.287-289. ⟨10.1016/j.mednuc.2020.06.002⟩
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique, 2020, 44, pp.287-289. ⟨10.1016/j.mednuc.2020.06.002⟩
Iodine-131 (131I, radioiodine) has been used for over eight decades for the treatment of Graves’ disease, either as initial therapy or following failure of thionamides, as well as for the treatment of autonomous thyroid nodules. 131I treatment is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53246a5e0c3cdc4f5fbcd2cbed547291
https://hal.archives-ouvertes.fr/hal-03493966
https://hal.archives-ouvertes.fr/hal-03493966
Publikováno v:
International Journal of Endocrine Oncology. 4:127-136
We describe the clinical ethics problem of American thyroid cancer patients being offered ‘observation’ instead of the USA standard of care with questionable informed consent. This problem arose because some American practitioners misinterpreted
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:e1901-e1902
Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis
Autor:
Kenneth B. Ain, Steven I. Sherman, Jacqueline Jonklaas, Paul W. Ladenson, Mingzhao Xing, Danielle R. Litofsky, Monica C. Skarulis, Harry R. Maxon, David S. Cooper, David L. Steward, Douglas S. Ross, Donald S. A. McLeod, James Magner, Henry G. Fein, Bryan R. Haugen, James D. Brierley
Publikováno v:
Thyroid. 25:1097-1105
Thyroid cancer is unique for having age as a staging variable. Recently, the commonly used age cut-point of 45 years has been questioned.This study assessed alternate staging systems on the outcome of overall survival, and compared these with current
Autor:
William LeMaster, Kenneth B. Ain, Brian T. Gold, Barbara Martin, Richard Grondin, Charles D. Smith
Publikováno v:
Thyroid. 25:28-36
Hypothyroidism has been associated with cognitive and motor impairments that are likely to constitute hazards in the operation of motor vehicles and a public safety risk. However, there is a paucity of data that would provide an evidence basis for re
Publikováno v:
International Journal of Endocrine Oncology. 1:145-151
Protein kinase inhibitors (PKIs) have emerged as highly promising therapies in progressive metastatic radioiodine-refractory differentiated thyroid cancer and in medullary thyroid cancer; two were recently approved in the USA for use in medullary thy
Autor:
Brandy Sumner, Fiona Hogan, Brindi Trickey-Platt, John C. Knight, Jean-Charles Chapuis, Ernest Hamel, Robin K. Pettit, George R. Pettit, Kenneth B. Ain, Rachel Dixon, Heidi J. Rosenberg
Publikováno v:
Journal of Natural Products. 75:385-393
Toward the objective of designing a structurally modified analogue of the combretastatin A-4 phosphate prodrug (1b) with the potential for increased specificity toward thyroid carcinoma, synthesis of a series of iodocombstatin phosphate (11a-h) and d
Autor:
Kenneth B Ain, Wei Li
Publikováno v:
Endocrine-Related Cancer. 17:383-398
Radioiodine remains the only tumoricidal therapy for disseminated thyroid carcinomas; however, dedifferentiated tumors lose the expression of human sodium–iodide symporter (hNIS) gene, and cannot respond to this treatment. Previous studies suggeste
Autor:
Steven I. Sherman, Monica C. Skarulis, Kenneth B. Ain, Douglas S. Ross, Bryan R. Haugen, James D. Brierley, Danielle R. Litofsky, Jacqueline Jonklaas, Paul W. Ladenson, Harry R. Maxon, David L. Steward, James Magner, Jacob Robbins, David S. Cooper, Thomas Bigos
Publikováno v:
Thyroid. 19:1043-1048
Despite very low mortality associated with micropapillary thyroid cancer, locoregional recurrence is common and controversy exists regarding optimal surgical treatment and the role of adjunctive radioiodine.The National Thyroid Cancer Treatment Coope
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:1080-1087
Context: Therapy of thyroid carcinoma uses its radioiodine concentration ability for treatment. Dedifferentiated cells lose radioiodine uptake from human sodium-iodide symporter (hNIS) gene transcription failure consequent to genomic structure (chrom